H.R. 384 · 118th Congress (2023–2025)
Protecting Life from Chemical Abortions Act
This bill nullifies certain changes made by the Food and Drug Administration (FDA) to dispensing requirements for mifepristone. (Mifepristone is a drug that is approved to end pregnancies through 10 weeks gestation when used in conjunction with the drug misoprostol. The procedure is often referred to as medication abortion or the abortion pill.)
The FDA regulates the use of mifepristone through the Mifepristone Risk Evaluation and Mitigation Strategy (REMS) program. The program requires health care providers to comply with certain requirements in order to prescribe or dispense mifepristone to end a pregnancy; the program previously included an in-person dispensing requirement that required mifepristone to be directly dispensed to patients in clinics, medical offices, or hospitals. During the COVID-19 public health emergency, the FDA temporarily stopped enforcing the in-person dispensing requirement, which allowed mail-order pharmacies to fill and dispense mifepristone prescriptions.
In January 2023, the FDA modified program requirements so as to (1) remove the in-person dispensing requirement, and (2) require pharmacies to be certified in the program in order to dispense mifepristone. The modifications allow retail pharmacies, after receiving certification, to dispense mifepristone pursuant to prescriptions that are written by program-certified prescribers.
The bill nullifies the January 2023 changes and prohibits the FDA from (1) exercising any enforcement discretion with respect to program requirements, or (2) reducing program protections until every state submits certain data regarding abortions to the Centers for Disease Control and Prevention.
The bill also generally prohibits the declaration of a public health emergency with respect to abortions.
Show official title
To prohibit the use or declaration of a public health emergency with respect to abortion, and for other purposes.
Expired in House committee
Derived from the legislative history, not an official disposition.
Latest actionReferred to Health
This bill’s path
This is H.R. 384’s recorded path, not a universal congressional workflow.
How bills become lawAll actionsIntroduced
Passed House
Passed Senate
Sent to President
Signed into law
Expired
- Sponsor
- Rep. Kevin Hern (R-OK-1)
- Cosponsors
40 cosponsors
34 original · 6 later
40 R
- Rep. Robert B. Aderholt (R-AL-4)· Original · Jan 17, 2023
- Rep. Lauren Boebert (R-CO-3)· Original · Jan 17, 2023
- Rep. Brian Babin (R-TX-36)· Original · Jan 17, 2023
- Rep. Jim Banks (R-IN-3)· Original · Jan 17, 2023
- Rep. James R. Baird (R-IN-4)· Original · Jan 17, 2023
- Rep. Andrew S. Clyde (R-GA-9)· Original · Jan 17, 2023
- Rep. Ben Cline (R-VA-6)· Original · Jan 17, 2023
- Rep. Jeff Duncan (R-SC-3)· Original · Jan 17, 2023
- Rep. Jake Ellzey (R-TX-6)· Original · Jan 17, 2023
- Rep. Randy Feenstra (R-IA-4)· Original · Jan 17, 2023
- Rep. Brad Finstad (R-MN-1)· Original · Jan 17, 2023
- Rep. Russell Fry (R-SC-7)· Original · Jan 17, 2023
- Rep. Paul A. Gosar (R-AZ-9)· Original · Jan 17, 2023
- Rep. Glenn Grothman (R-WI-6)· Original · Jan 17, 2023
- Rep. Mark E. Green (R-TN-7)· Original · Jan 17, 2023
- Rep. Michael Guest (R-MS-3)· Original · Jan 17, 2023
- Rep. Diana Harshbarger (R-TN-1)· Original · Jan 17, 2023
- Rep. Ashley Hinson (R-IA-2)· Original · Jan 17, 2023
- Rep. Ronny Jackson (R-TX-13)· Original · Jan 17, 2023
- Rep. Trent Kelly (R-MS-1)· Original · Jan 17, 2023
- Rep. Doug Lamborn (R-CO-5)· Original · Jan 17, 2023
- Rep. Doug LaMalfa (R-CA-1)· Original · Jan 17, 2023
- Rep. Barry Loudermilk (R-GA-11)· Original · Jan 17, 2023
- Rep. Nicholas A. Langworthy (R-NY-23)· Original · Jan 17, 2023
- Rep. John R. Moolenaar (R-MI-2)· Original · Jan 17, 2023
- Rep. Brian J. Mast (R-FL-21)· Original · Jan 17, 2023
- Rep. Mary E. Miller (R-IL-15)· Original · Jan 17, 2023
- Rep. August Pfluger (R-TX-11)· Original · Jan 17, 2023
- Rep. John H. Rutherford (R-FL-5)· Original · Jan 17, 2023
- Rep. John W. Rose (R-TN-6)· Original · Jan 17, 2023
- Rep. Pete Sessions (R-TX-17)· Original · Jan 17, 2023
- Rep. Daniel Webster (R-FL-11)· Original · Jan 17, 2023
- Rep. Randy K. Weber, Sr. (R-TX-14)· Original · Jan 17, 2023
- Rep. Brad R. Wenstrup (R-OH-2)· Original · Jan 17, 2023
- Rep. Mike Bost (R-IL-12)· Later · Mar 21, 2023
- Rep. Bob Good (R-VA-5)· Later · Mar 21, 2023
- Rep. Keith Self (R-TX-3)· Later · Mar 21, 2023
- Rep. Rudy Yakym III (R-IN-2)· Later · Mar 21, 2023
- Rep. Dan Crenshaw (R-TX-2)· Later · Sep 18, 2023
- Rep. Dan Newhouse (R-WA-4)· Later · Mar 29, 2024
- Policy area
- Health
On this page
Timeline
i
In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.
Introduced in House
Document: Introduced in House
Sources
- Congress.gov actionIntro-H
- Library of Congress
- Latest
▸ 2 committee actions · Jan 17, 2023 – Jan 27, 2023
Referred to committee
Referred to the House Committee on Energy and Commerce.
Sources
- Congress.gov action
- House floor actions
Referred to Health
Referred to the Subcommittee on Health.
Sources
- Congress.gov action
- House committee actions
Expired
Introduced → Referred to House Health → No further action before the 118th Congress ended.
Committees
Text & titles
i
Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.
| Version | Date | Links |
|---|---|---|
| Introduced in House |
Titles (2)
Protecting Life from Chemical Abortions Act
Display title, Short title · Introduced in House
To prohibit the use or declaration of a public health emergency with respect to abortion, and for other purposes.
Official title · Introduced in House